Dr. Peters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
# Shapiro
Boston, MA 02215Phone+1 617-667-2100Fax+1 617-975-5665
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Massachusetts Medical SchoolClass of 2011
Stanford UniversityMS, 1993 - 1995
Massachusetts Institute of TechnologySB, Biology, French Literature, 1988 - 1992
Certifications & Licensure
MA State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Start of enrollment: 2020 Oct 16
Roles: Contact
- Futibatinib in Patients With Specific FGFR Aberrations Start of enrollment: 2020 Aug 24
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsGenetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.Mary Linton B Peters, Andrew Eckel, Anna Lietz, Claudia Seguin, Peter Mueller
Pancreatology. 2022-09-01 - 20 citationsDuration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.Peter P Mueller, Qiushi Chen, Turgay Ayer, Gizem S Nemutlu, Ali Hajjar
Journal of Hepatology. 2022-07-01 - 54 citationsOrganoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer.Joseph E. Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea
Clinical Cancer Research. 2021-11-17
Grant Support
- Cost Effectiveness of Germline Genetic Testing in Pancreatic CancerBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
Professional Memberships
- Member
- Member
- Society for Medical Decision MakingMember
- Society of Decision ProfessionalsFellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
